Speed, scale, simplicity

The future of genomic medicines

Scenic aerial view of peoppe walking on pink salt lake

The treatment of “Baby KJ” Muldoon represents a new era for genomic medicines—one where personalized therapies are created rapidly to address the root cause of a disease. Could custom CRISPR therapies be designed and delivered at the scale needed to transform human health?

Historic first: Infant receives tailored CRISPR therapy faster than ever

Baby KJ is the first person to ever receive a CRISPR therapy tailored to their unique disease-causing mutation. Added to this major medical advance was an equally impressive manufacturing advance.  

Sadik Kassim, CTO, LS Omics Solutions at Danaher, joined CNN to discuss how Baby KJ's therapy was designed and manufactured in record time—and how this work lays the groundwork for treating a broader range of rare genetic disorders. 
 

Building the blueprint for scalable CRISPR

“We can develop CRISPR cures in a laboratory, but at the end of the day, we need a way to turn those into clinical products for thousands of patients.”
 
Jennifer Doudna, IGI Founder, Nobel Laureate and Danaher collaborator

What happens when scientific giants unite to rethink the limits of gene editing? A lot more than just breakthroughs—it’s the beginning of a blueprint for making CRISPR scalable, accessible and transformative. In this exclusive Q&A, Danaher leaders Sadik Kassim and Vanessa Almendro, Head of Science & Technology Innovation, unpack the vision, the challenges and the collaborative spark driving the next era of genomic medicine. Curious how the future is being built? Start here.

Read the Q&A

Further reading

Collaborating for impact

Gene editing

Danaher-IGI Beacon for CRISPR Cures

This collaborative center aims to develop gene-editing cures for rare and other diseases on an unprecedented scale. Using the programmable power of CRISPR, it aims to permanently address hundreds of conditions through a unified research, development, and regulatory model—reshaping how genomic medicines are developed and deployed.

Learn more
Close-up of a mother holding her baby boy near her face. The baby boy is laughing looking away from the camera making his mother laugh.

Center for Pediatric CRISPR Cures

The Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) have launched a new center that will use CRISPR-based gene editing technology to advance cures for several pediatric genetic diseases, with Danaher providing the essential manufacturing infrastructure to support this work.

Learn more

Read more

A Baby Receives the First Customized CRISPR Treatment

 TIME Magazine

A Baby Received a Custom Crispr Treatment in Record Time

WIRED

ASGCT 2025: World’s First Patient Treated with Personalized CRISPR Therapy

GEN